4//SEC Filing
Litchman Manuel MD 4
Accession 0001104659-25-040237
CIK 0001680048other
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 4:30 PM ET
Size
5.1 KB
Accession
0001104659-25-040237
Insider Transaction Report
Form 4
Litchman Manuel MD
DirectorPresident, CEO and Interim CFO
Transactions
- Tax Payment
COMMON STOCK
2025-04-24$1.24/sh−27$33→ 1,634 total
Footnotes (2)
- [F1]27 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units.
- [F2]Effective January 15, 2025, the Issuer effected a one-for-fifty reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.
Documents
Issuer
MUSTANG BIO, INC.
CIK 0001680048
Entity typeother
Related Parties
1- filerCIK 0001709485
Filing Metadata
- Form type
- 4
- Filed
- Apr 27, 8:00 PM ET
- Accepted
- Apr 28, 4:30 PM ET
- Size
- 5.1 KB